FACTORS ASSOCIATED WITH DEVELOPING CHRONIC DAILY HEADACHE IN MIGRAINE PATIENTS

Z AYAZ; Z ALI

doi:10.54112/bcsrj.v2024i1.723

Authors

Z AYAZ Department of Medicine, Lady Reading Hospital-MTI, Peshawar, Pakistan
Z ALI Department of Medicine, Lady Reading Hospital-MTI, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.723

Keywords:

Migraine, Chronic daily headache, Factors, Obesity

Abstract

To examine the factors associated with developing chronic daily headache in migraine patients. Two hundred patients with migraine were selected for this descriptive study conducted from 01-Sept-2023 to 30-Nov-2023 at the Department of Medicine, Lady Reading Hospital, Medical Teaching Institution, Peshawar. Factors associated with developing chronic daily headache were assessed. SPSS 23 was employed for analyzing the data. The mean age was 38.09±12.03 years. The frequency of chronic daily headache in our study was 31 (15.5%). Female gender (p = 0.02), smoking (p = 0.0001), high caffeine intake (p = 0.0001), painkiller overuse (p = 0.0001) and obesity (p = 0.0001) were factors significantly identified for developing chronic daily headache. We conclude that the factors for developing chronic daily headache in migraine patients were female gender, smoking, high intake of pain relieving medicines, high intake of caffeinated drinks and obesity.

Downloads

Download data is not yet available.

References

Bigal, M. E., and Lipton, R. B. (2006). Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67, 252-257.

Buse, D. C., Reed, M. L., Fanning, K. M., Bostic, R., Dodick, D. W., Schwedt, T. J., Munjal, S., Singh, P., and Lipton, R. B. (2020). Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. The journal of headache and pain 21, 1-16.

Castillo, J., Muñoz, P., Guitera, V., and Pascual, J. (1999). Epidemiology of chronic daily headache in the general population. Headache: The Journal of Head and Face Pain 39, 190-196.

Cooper, W., Doty, E. G., Hochstetler, H., Hake, A., and Martin, V. (2020). The current state of acute treatment for migraine in adults in the United States. Postgraduate Medicine 132, 581-589.

Diener, H.-C., Holle, D., Dresler, T., and Gaul, C. (2018). Chronic headache due to overuse of analgesics and anti-migraine agents. Deutsches Ärzteblatt International 115, 365.

Garramone, F., Baiano, C., Russo, A., D’Iorio, A., Tedeschi, G., Trojano, L., and Santangelo, G. (2020). Personality profile and depression in migraine: a meta-analysis. Neurological sciences 41, 543-554.

Garrigós-Pedrón, M., La Touche, R., Navarro-Desentre, P., Gracia-Naya, M., and Segura-Orti, E. (2019). Widespread mechanical pain hypersensitivity in patients with chronic migraine and temporomandibular disorders: relationship and correlation between psychological and sensorimotor variables. Acta Odontologica Scandinavica 77, 224-231.

Goadsby, P., Zanchin, G., Geraud, G. a., De Klippel, N., Diaz-Insa, S., Gobel, H., Cunha, L., Ivanoff, N., Falques, M., and Fortea, J. (2008). Early vs. non-early intervention in acute migraine—‘Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 28, 383-391.

Grande, R. B., Aaseth, K., Gulbrandsen, P., Lundqvist, C., and Russell, M. B. (2008). Prevalence of primary chronic headache in a population-based sample of 30-to 44-year-old persons: the Akershus study of chronic headache. Neuroepidemiology 30, 76-83.

Karbowniczek, A., and Domitrz, I. (2011). Frequency and clinical characteristics of chronic daily headache in an outpatient clinic setting. Neurologia i neurochirurgia polska 45, 11-17.

Korkmaz, S., Kazgan, A., Korucu, T., Gönen, M., Yilmaz, M. Z., and Atmaca, M. (2019). Psychiatric symptoms in migraine patients and their attitudes towards psychological support on stigmatization. Journal of Clinical Neuroscience 62, 180-183.

Kuca, B., Silberstein, S. D., Wietecha, L., Berg, P. H., Dozier, G., Lipton, R. B., Group, C. M.-S., and Group, C. M.-S. (2018). Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study. Neurology 91, e2222-e2232.

Lu, S., Fuh, J., Chen, W., Juang, K., and Wang, S. (2001). Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21, 980-986.

Manack, A., Buse, D., Serrano, D., Turkel, C., and Lipton, R. (2011). Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76, 711-718.

Park, J.-W., Moon, H.-S., Kim, J.-M., Lee, K.-S., and Chu, M. K. (2014). Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. Journal of Clinical Neurology 10, 236-243.

Queiroz, L., Peres, M., Kowacs, F., Piovesan, E., Ciciarelli, M., Souza, J., and Zukerman, E. (2008). Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia 28, 1264-1269.

Rainero, I., Vacca, A., Govone, F., Gai, A., Pinessi, L., and Rubino, E. (2019). Migraine: genetic variants and clinical phenotypes. Current Medicinal Chemistry 26, 6207-6221.

Scher, A., Stewart, W., Ricci, J., and Lipton, R. (2003). Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106, 81-89.

Scher, A. I., Midgette, L. A., and Lipton, R. B. (2008). Risk factors for headache chronification. Headache: The Journal of Head and Face Pain 48, 16-25.

Schramm, S. H., Obermann, M., Katsarava, Z., Diener, H.-C., Moebus, S., and Yoon, M.-S. (2013). Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. The journal of headache and pain 14, 1-8.

Schwedt, T. J. (2014). Chronic migraine. Bmj 348.

Schwedt, T. J., Alam, A., Reed, M. L., Fanning, K. M., Munjal, S., Buse, D. C., Dodick, D. W., and Lipton, R. B. (2018). Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. The journal of headache and pain 19, 1-9.

Society, H. C. C. o. t. I. H. (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8, 1-96.

Society, H. C. S. o. t. I. H. (2004). The international classification of headache disorders. cephalalgia 24, 9-160.

Teckchandani, S., and Cowan, R. (2019). Chronic Daily Headache: Do We Know It When We See It? Chronic Headache: A Comprehensive Guide to Evaluation and Management, 1-10.

Vukovic Cvetkovic, V., and Jensen, R. H. (2019). Neurostimulation for the treatment of chronic migraine and cluster headache. Acta Neurologica Scandinavica 139, 4-17.

Wang, S.-J., Fuh, J.-L., Lu, S.-R., Liu, C.-Y., Hsu, L.-C., Wang, P.-N., and Liu, H.-C. (2000). Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 54, 314-314.

Yamani, N., and Olesen, J. (2019). New daily persistent headache: a systematic review on an enigmatic disorder. The journal of headache and pain 20, 1-9.